Nouvelle déclaration d'incident
No de la demande: 2013-6655
Numéro de référence du titulaire d'homologation: 5132683
Nom du titulaire (nom légal complet, aucune abbréviation): Sure-Gro Inc.
Adresse: 150 Savannah Oaks Dr.
Ville: Brantford
État: Ontario
Pays: Canada
Code postal /Zip: N3V 1E7
Incident chez un animal domestique
Pays: CANADA
État: NEWFOUNDLAND
ARLA No d'homologation 28352 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Wilson Predator Rat and Mouse Killer
Inconnu
Inconnu
Propriétaire de l'animal
Dog / Chien
unknown
1
Femme
1
20
lbs
Orale
>24 hrs <=3 days / >24 h <=3 jours
Unknown / Inconnu
Système
Unknown / Inconnu
Inconnu
Inconnu
Unknown/Inconnu
Accidental ingestion/Ingestion accident.
(p.ex. description des symptômes tels que la fréquence et la gravité
Caller stated that the dog's family was visting the caller since Friday. This morning, she passed bait in her stool. [Name] found crumbles of the block and thinks that the dog ingested the block last evening. Discussed the case with [Name]. She will contact the dog owners and have them take her to the vet tonight or by tomorrow am at the latest. Caller was advised that since the dog was at the house with the bait since Friday, it would be best to begin the vitamin K today. The owners are on the way home with (name).TOE1 day. The dog ate one of the blocks and is over the toxic threshold according to calculations so the call was transferred to the NAPCC. The caller stated that the dog's feces is a dark green color. O. Dark green feces Symptoms: Other A. Acute, dog, ingestion R. NAPCC 130104380 Therapies: Unknown if therapy provided
Mineure
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified.